VISA
8.11.2021 11:02:11 CET | Business Wire | Press release
As a result of a new global technology partnership between Daimler Mobility and Visa, Daimler will offer “native” in-car payments. This means that entering passwords or relying on mobile devices for payment authentication may soon be a thing of the past as the vehicle itself becomes a biometrically enabled payments device, thanks to Visa’s Delegated Authentication technology.
From spring 2022 onwards, Mercedes-Benz customers in the UK and Germany will be able to make payments using a fingerprint sensor in the car, with other European markets to follow. Purchases can then be made directly through the car’s head unit, or MBUX. The solution is anticipated to be available in other markets globally at a later stage.
In-car commerce has become an integral aspect of the luxury customer experience. For example, Daimler Mobility's global payment platform called Mercedes pay enables customers to buy goods and services directly in their car, including Mercedes me services, as well as for other use cases such as fuelling and parking.
Antony Cahill, Deputy CEO and Head of European Markets, at Visa in Europe:
"We are excited to bring to life a native solution for in-car payments for the first time, together with our partner Daimler Mobility. It is significant that both the successful pilot testing and initial launch activities are taking place in Europe, a world-leading hub for payments and automotive innovation. This is a powerful example of how the world’s leader in digital payments and the inventor of the automobile are able to combine their technologies to create the next generation of smart solutions for the automobility sector, providing the driver and passengers with a completely new in-car connected commerce experience.”
Franz Reiner, Chief Executive Officer, Daimler Mobility:
“Mercedes pay is our competence centre for in-car payment, through which we offer our customers worldwide digital services seamlessly integrated within the Mercedes-Benz ecosystem. In partnership with Visa, Daimler aims to offer native in-car payments that meet the requirements of two-factor authentication in a secure and user-friendly way. There is nothing more convenient than authorising a payment with your fingerprint. A luxury customer experience of course includes the aspect of safety, and we fulfil that through native in-car payment. We offer our customers security not only when driving, but also when paying.”
The technology behind native in-car digital commerce
Mercedes pay is a component of Daimler’s mobility and digitalization strategy, and a business segment of Daimler Mobility. Daimler will be the first ever automotive company in the world to incorporate the Visa Cloud Token Framework into its vehicles. Visa’s Cloud Token Framework is a cloud-based security technology that allows more flexibility across multiple devices as Visa Cloud Tokens protect and remove sensitive payment information by converting data and storing it securely. They also enable multiple device pairing in and beyond the car, which are then directly integrated with the consumer’s bank credentials. This significantly improves the overall payment experience as consumers no longer need to enter long card numbers to complete a purchase or switch between devices to authenticate payments. The solution will be used to initiate a two-factor authentication1 .
Promising future for in-car digital commerce
In the next two years alone, the number of connected cars is estimated to increase to more than 352 million worldwide2 and the total volume of in-car payments is set to reach approximately $86 billion by 20253 .
Mobility trends like electric vehicles, car sharing, autonomous driving and connected cars are increasing the demand for innovative payment methods within the vehicle itself. Today, when you buy car-related services, many require the motorist to use a separate device to log onto an app or website. Daimler and Visa’s ambition is to enable users to have a hassle-free payments experience through the car, while also expanding the choice and quality of experiences available to them.
Daimler Mobility at a Glance
In addition to Mercedes-Benz AG and Daimler Truck AG, Daimler Mobility AG is one of the three business divisions of Daimler AG. It has about 11,650 employees and specializes in financial and mobility solutions. Its products range from leasing, financing, and insurance products to innovative fleet management systems and app-based mobility services. As a financial services provider, the business division supports the sales of the Daimler Group’s automotive brands worldwide. In Germany, Mercedes-Benz Bank AG, part of the Daimler Mobility division, is one of the country’s leading automotive banks. It provides around one million customers with financial leeway as well as call-money and fixed-interest-rate accounts in the direct banking business. The product range is supplemented by flexible mobility services such as Mercedes-Benz Rent and EQ subscriptions, which enable an uncomplicated and flexible entry into electro mobility. Through its subsidiary Athlon, Daimler Mobility is represented in the commercial fleet management segment as well as in vehicle leasing in Europe. The company manages more than 400,000 vehicles in total. As a strategic investor, Daimler Mobility also participates in the business potential of digital mobility solutions through its holdings. The focus is on its involvement in FREE NOW, SHARE NOW and CHARGE NOW. These pillars combine ride-hailing, carsharing, multimodal mobility and the charging of electric vehicles. Daimler Mobility’s portfolio also contains holdings in the limousine ride-hailing service StarRides in China and the chauffeur service provider Blacklane. In 2020, Daimler Mobility financed or leased around 50 percent of the vehicles sold by Daimler worldwide. This corresponds to a contract volume of €150.6 billion. In 2020, the business division generated revenue of €27.7 billion and achieved EBIT of €1.4 billion. Daimler Mobility operates in 39 countries.
LinkedIn: https://www.linkedin.com/company/daimler-mobility
About Visa Inc.
Visa Inc. (NYSE: V) is the world’s leader in digital payments. Our mission is to connect the world through the most innovative, reliable and secure payment network - enabling individuals, businesses and economies to thrive. Our advanced global processing network, VisaNet, provides secure and reliable payments around the world, and is capable of handling more than 65,000 transaction messages a second. The company’s relentless focus on innovation is a catalyst for the rapid growth of digital commerce on any device for everyone, everywhere. As the world moves from analogue to digital, Visa is applying our brand, products, people, network and scale to reshape the future of commerce. For more information, visit About Visa , visa.com/blog and @VisaNews .
1 Strong Customer Authentication (SCA) compliance requires two-factor authentication consisting of the following: something the consumer knows (e.g. a password), possess (e.g. a connected device) or is (e.g. biometrics). Daimler Mobility makes use of Visa’s Delegated Authentication Service, making it possible to apply SCA on behalf of the issuer.
2 Capgemini Invent: Connected Vehicle Trend Radar 2 , 2020.
3 Juniper Research: The Race for In-Vehicle Payments , 2020.
View source version on businesswire.com: https://www.businesswire.com/news/home/20211108005472/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Phase 3 RAINIER Results Supporting Best-in-Class Potential of Povetacicept in IgA Nephropathy Published in the New England Journal of Medicine and Presented at the American Society of Nephrology Kidney Week 202623.10.2026 19:42:00 CEST | Press release
- Vertex is on track for the U.S. FDA Prescription Drug User Fee Act (PDUFA) date of November 30 for potential accelerated approval of povetacicept –- Data published in NEJM and presented at ASN highlight povetacicept’s unique trifecta of efficacy, favorable safety, and the simplicity of dosing at-home every 4 weeks with a low-volume autoinjector –- Data presented at ASN include a qualitative study examining patient perspectives on current and emerging IgAN therapies, showing that 96% of participants preferred an autoinjector over a prefilled syringe, and 80% of participants preferred dosing every 4 weeks versus weekly dosing - - New clinical studies of povetacicept underway including a study evaluating patient experience on povetacicept administered via autoinjector - Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the publication of Phase 3 RAINIER results for povetacicept in the New England Journal of Medicine (NEJM), presentation of these data at the American Soc
BeOne Medicines Reports Sustained Survival Benefit with TEVIMBRA-ZIIHERA Combination in First-Line HER2+ Gastroesophageal Cancer23.10.2026 16:15:00 CEST | Press release
New data from HERIZON-GEA-01 Phase 3 trial show 36-month overall survival of nearly 40% with TEVIMBRA plus ZIIHERA and chemotherapy, and median OS reaching 27 monthsTEVIMBRA-containing arm was associated with a four-month longer median OS compared with ZIIHERA plus chemotherapy BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new survival results from the planned second interim analysis (IA2) and final formal analysis of the Phase 3 HERIZON-GEA-01 trial, further confirming the benefit of TEVIMBRA® (tislelizumab) plus ZIIHERA® (zanidatamab) and chemotherapy as first-line treatment for patients with HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). The results will be presented today as a late-breaking abstract during a rapid oral session at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, Spain (LBA79). Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne,
Lifezone Metals Confirms Advanced Negotiations with Orion CMC on Kabanga Nickel Project23.10.2026 16:10:00 CEST | Press release
Lifezone Metals Limited (NYSE: LZM) notes comments made today by Oskar Lewnowski, Founder and Group Chief Executive of Orion Resource Partners, in an interview with Bloomberg Television regarding the Company’s Kabanga Nickel Project in Tanzania. In response to inbound inquiries from media outlets and investors following the interview, the Company can confirm that negotiations with Orion Critical Mineral Consortium (Orion CMC) regarding a significant equity investment into the Kabanga Nickel Project are at an advanced stage. The Orion CMC is a global investment platform launched by Orion Resource Partners in partnership with the U.S. International Development Finance Corporation (DFC) and Abu Dhabi's sovereign investor ADQ. As previously announced, the Company has been running a competitive process, led by Standard Chartered Bank, to secure a strategic investment into the Kabanga Nickel Project. Social Media LinkedIn | X | YouTube About Lifezone Metals Lifezone Metals (NYSE: LZM) is com
inDrive and Pony.ai Announce Collaboration to Explore Autonomous Mobility in Kazakhstan Built on NVIDIA Hyperion23.10.2026 15:00:00 CEST | Press release
Collaboration will establish the roadmap for bringing Pony.ai robotaxis to Kazakhstan on the inDrive ride-hailing platform, leveraging the NVIDIA Hyperion and the NVIDIA Halos safety system. inDrive, the global mobility and delivery platform, today announced it has signed a memorandum of understanding (MOU) with NVIDIA and Pony.ai, a global leader in the large-scale commercialization of autonomous driving technology, to explore the future of autonomous ride-hailing. Kazakhstan will serve as the first test market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261023143469/en/ inDrive partners with Pony.ai and NVIDIA to explore autonomous mobility in Kazakhstan Kazakhstan was chosen first for its regulatory readiness following the creation of the country’s first structured legal framework for driverless transport, as part of its “Year of Digitalization and Artificial Intelligence.” Combined with Kazakhstan’s position as a lea
Brenus Pharma's Novel In Vivo Immunotherapy STC-1010 Shows Safety, Activating T Cells in First-Line MSS Metastatic Colorectal Cancers With 2 Complete Responses.23.10.2026 14:50:00 CEST | Press release
Phase Ia BreAK CRC-001 at ESMO 2026: 43% of patients, all initially unresectable, became eligible for surgery Poster 1023P – Developmental Therapeutics Brenus Pharma, a clinical-stage biotech company, announced first data from the Phase Ia dose escalation of BreAK CRC-001. Nine unresectable patients were treated; 89% had liver metastases and 89% KRAS-mutant tumors, a population refractory to immunotherapy. Median follow-up: 8 months (1–14; data cut-off 6/08/2026). 95% of metastatic colorectal cancers are pMMR/MSS tumors, poorly immunogenic and resistant to immunotherapy. STC-1010, the company’s lead in vivo DC-engager, is designed to make these “cold” tumors visible to immune cells. Safety: no dose-limiting toxicity, only grade 1–2 related adverse events. Clinical activity (seven evaluable patients, RECIST 1.1): 100% disease control, 57% objective response rate (4/7). 43% of patients became operable (3/7): two with no evidence of disease afterward. Molecular profile: ctDNA dropped by u
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
